Compendium of Cancer Genome Aberrations

ENDO5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
Newer edit →
VisualWikitext
Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo..."
 
No edit summary
Line 17: Line 17:
!'''Notes'''
!'''Notes'''
|-
|-
|[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[ENDO5:Mammosomatotroph_PitNET/adenoma|Mammosomatotroph PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 27: Line 39:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Lactotroph_PitNET/adenoma|Lactotroph PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 36: Line 50:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Thyrotroph_PitNET/adenoma|Thyrotroph PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 45: Line 61:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Mature_plurihormonal_PIT1-lineage_PitNET/adenoma|Mature plurihormonal PIT1-lineage PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 54: Line 72:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Immature_PIT1-lineage_PitNET/adenoma|Immature PIT1-lineage PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 63: Line 83:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Acidophil_stem_cell_PitNET/adenoma|Acidophil stem cell PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 72: Line 94:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Mixed_somatotroph-lactotroph_PitNET/adenoma|Mixed somatotroph-lactotroph PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 81: Line 105:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Corticotroph_PitNET/adenoma|Corticotroph PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 90: Line 116:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Gonadotroph_PitNET/adenoma|Gonadotroph PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 99: Line 127:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Null_cell_PitNET/adenoma|Null cell PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 108: Line 138:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Plurihormonal_PitNET/adenomas|Plurihormonal PitNET/adenomas]]
|Disease
|
|
|
|
|
Line 117: Line 149:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Multiple_synchronous_PitNET/adenomas_of_distinct_lineages|Multiple synchronous PitNET/adenomas of distinct lineages]]
|Disease
|
|
|
|
|
Line 126: Line 160:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Metastatic_PitNET|Metastatic PitNET]]
|Disease
|
|
|
|
|
Line 135: Line 171:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|Disease
|
|
|
|
|
Line 144: Line 182:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|Disease
|
|
|
|
|
Line 153: Line 193:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Pituitary_blastoma|Pituitary blastoma]]
|Disease
|
|
|
|
|
Line 162: Line 204:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Pituicytomas|Pituicytomas]]
|Disease
|
|
|
|
|
Line 171: Line 215:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Gangliocytoma_and_mixed_gangliocytoma-PitNET/adenoma|Gangliocytoma and mixed gangliocytoma-PitNET/adenoma]]
|Disease
|
|
|
|
|
Line 180: Line 226:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Sellar_neurocytoma|Sellar neurocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Meningiomas|Meningiomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Chordoma|Chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Other_congenital_thyroid_abnormalities|Other congenital thyroid abnormalities]]
|Disease
|
|
|
|
|
Line 189: Line 281:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Thyroid_follicular_nodular_disease|Thyroid follicular nodular disease]]
|Disease
|
|
|
|
|
Line 198: Line 292:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Follicular_thyroid_adenoma|Follicular thyroid adenoma]]
|Disease
|
|
|
|
|
Line 207: Line 303:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Follicular_thyroid_adenoma_with_papillary_architecture|Follicular thyroid adenoma with papillary architecture]]
|Disease
|
|
|
|
|
Line 216: Line 314:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Oncocytic_adenoma_of_the_thyroid|Oncocytic adenoma of the thyroid]]
|Disease
|
|
|
|
|
Line 225: Line 325:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Non-invasive_follicular_thyroid_neoplasm_with_papillary-like_nuclear_features|Non-invasive follicular thyroid neoplasm with papillary-like nuclear features]]
|Disease
|
|
|
|
|
Line 234: Line 336:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Thyroid_tumours_of_uncertain_malignant_potential|Thyroid tumours of uncertain malignant potential]]
|Disease
|
|
|
|
|
Line 243: Line 347:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Hyalinizing_trabecular_tumour|Hyalinizing trabecular tumour]]
|Disease
|
|
|
|
|
Line 252: Line 358:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Follicular_thyroid_carcinoma|Follicular thyroid carcinoma]]
|Disease
|
|
|
|
|
Line 261: Line 369:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Invasive_encapsulated_follicular_variant_of_papillary_thyroid_carcinoma|Invasive encapsulated follicular variant of papillary thyroid carcinoma]]
|Disease
|
|
|
|
|
Line 270: Line 380:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Papillary_thyroid_carcinoma|Papillary thyroid carcinoma]]
|Disease
|
|
|
|
|
Line 279: Line 391:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Oncocytic_carcinoma_of_the_thyroid|Oncocytic carcinoma of the thyroid]]
|Disease
|
|
|
|
|
Line 288: Line 402:
|
|
|-
|-
| ||Disease||
|[[ENDO5:High-grade_follicular_cell-derived_non-anaplastic_thyroid_carcinoma|High-grade follicular cell-derived non-anaplastic thyroid carcinoma]]
|Disease
|
|
|
|
|
Line 297: Line 413:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Anaplastic_thyroid_carcinoma|Anaplastic thyroid carcinoma]]
|Disease
|
|
|
|
|
Line 306: Line 424:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Medullary_thyroid_carcinoma|Medullary thyroid carcinoma]]
|Disease
|
|
|
|
|
Line 315: Line 435:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Mixed_medullary_and_follicular_cell-derived_thyroid_carcinomas|Mixed medullary and follicular cell-derived thyroid carcinomas]]
|Disease
|
|
|
|
|
Line 324: Line 446:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
|Disease
|
|
|
|
|
Line 333: Line 457:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Secretory_carcinoma|Secretory carcinoma]]
|Disease
|
|
|
|
|
Line 342: Line 468:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Sclerosing_mucoepidermoid_carcinoma_with_eosinophilia|Sclerosing mucoepidermoid carcinoma with eosinophilia]]
|Disease
|
|
|
|
|
Line 351: Line 479:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Cribriform_morular_thyroid_carcinoma|Cribriform morular thyroid carcinoma]]
|Disease
|
|
|
|
|
Line 360: Line 490:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Thymoma|Thymoma]]
|Disease
|
|
|
|
|
Line 369: Line 501:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Spindle_epithelial_tumour_with_thymus-like_elements|Spindle epithelial tumour with thymus-like elements]]
|Disease
|
|
|
|
|
Line 378: Line 512:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Intrathyroidal_thymic_carcinoma|Intrathyroidal thymic carcinoma]]
|Disease
|
|
|
|
|
Line 387: Line 523:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Thyroblastoma|Thyroblastoma]]
|Disease
|
|
|
|
|
Line 396: Line 534:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]]
|Disease
|
|
|
|
|
Line 405: Line 545:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Parathyroid_adenoma|Parathyroid adenoma]]
|Disease
|
|
|
|
|
Line 414: Line 556:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Parathyroid_lipoadenoma|Parathyroid lipoadenoma]]
|Disease
|
|
|
|
|
Line 423: Line 567:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Atypical_parathyroid_tumour|Atypical parathyroid tumour]]
|Disease
|
|
|
|
|
Line 432: Line 578:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Parathyroid_carcinoma|Parathyroid carcinoma]]
|Disease
|
|
|
|
|
Line 441: Line 589:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Adrenal_rests|Adrenal rests]]
|Disease
|
|
|
|
|
Line 450: Line 600:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Adrenal_cysts|Adrenal cysts]]
|Disease
|
|
|
|
|
Line 459: Line 611:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Adrenal_myelolipoma|Adrenal myelolipoma]]
|Disease
|
|
|
|
|
Line 468: Line 622:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Congenital_adrenal_hyperplasia|Congenital adrenal hyperplasia]]
|Disease
|
|
|
|
|
Line 477: Line 633:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Adrenocortical_nodular_disease|Adrenocortical nodular disease]]
|Disease
|
|
|
|
|
Line 486: Line 644:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Adrenal_cortical_adenoma|Adrenal cortical adenoma]]
|Disease
|
|
|
|
|
Line 495: Line 655:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Adrenal_cortical_carcinoma|Adrenal cortical carcinoma]]
|Disease
|
|
|
|
|
Line 504: Line 666:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Adrenal_sex_cord_stromal_tumour|Adrenal sex cord stromal tumour]]
|Disease
|
|
|
|
|
Line 513: Line 677:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Adenomatoid_tumour|Adenomatoid tumour]]
|Disease
|
|
|
|
|
Line 522: Line 688:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Adrenal_melanoma|Adrenal melanoma]]
|Disease
|
|
|
|
|
Line 531: Line 699:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Neuroblastoma|Neuroblastoma]]
|Disease
|
|
|
|
|
Line 540: Line 710:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Ganglioneuroblastoma,_intermixed|Ganglioneuroblastoma, intermixed]]
|Disease
|
|
|
|
|
Line 549: Line 721:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Ganglioneuroblastoma,_nodular|Ganglioneuroblastoma, nodular]]
|Disease
|
|
|
|
|
Line 558: Line 732:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Ganglioneuroma|Ganglioneuroma]]
|Disease
|
|
|
|
|
Line 567: Line 743:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Phaeochromocytoma|Phaeochromocytoma]]
|Disease
|
|
|
|
|
Line 576: Line 754:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Sympathetic_paraganglioma|Sympathetic paraganglioma]]
|Disease
|
|
|
|
|
Line 585: Line 765:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Parasympathetic_paraganglioma|Parasympathetic paraganglioma]]
|Disease
|
|
|
|
|
Line 594: Line 776:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Composite_phaeochromocytomas_and_paragangliomas|Composite phaeochromocytomas and paragangliomas]]
|Disease
|
|
|
|
|
Line 603: Line 787:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]]
|Disease
|
|
|
|
|
Line 612: Line 798:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Insulinoma|Insulinoma]]
|Disease
|
|
|
|
|
Line 621: Line 809:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Glucagonoma|Glucagonoma]]
|Disease
|
|
|
|
|
Line 630: Line 820:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Somatostatinoma|Somatostatinoma]]
|Disease
|
|
|
|
|
Line 639: Line 831:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Gastrinoma|Gastrinoma]]
|Disease
|
|
|
|
|
Line 648: Line 842:
|
|
|-
|-
| ||Disease||
|[[ENDO5:VIPoma|VIPoma]]
|Disease
|
|
|
|
|
Line 657: Line 853:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Serotonin-producing_tumours_with_and_without_carcinoid_syndrome|Serotonin-producing tumours with and without carcinoid syndrome]]
|Disease
|
|
|
|
|
Line 666: Line 864:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Other_pancreatic_neuroendocrine_tumours_with_ectopic_hormone_production|Other pancreatic neuroendocrine tumours with ectopic hormone production]]
|Disease
|
|
|
|
|
Line 675: Line 875:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
Line 684: Line 886:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Mixed_ductal_adenocarcinoma-neuroendocrine_neoplasms|Mixed ductal adenocarcinoma-neuroendocrine neoplasms]]
|Disease
|
|
|
|
|
Line 693: Line 897:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Mixed_acinar-neuroendocrine_carcinoma|Mixed acinar-neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
Line 702: Line 908:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]]
|Disease
|
|
|
|
|
Line 711: Line 919:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
Line 720: Line 930:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
Line 729: Line 941:
|
|
|-
|-
| ||Disease||
|[[ENDO5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
|Disease
|
|
|
|
|
Line 738: Line 952:
|
|
|-
|-
|[[ENDO5:Mixed_neuroendocrine-non-neuroendocrine_neoplasms|Mixed neuroendocrine-non-neuroendocrine neoplasms]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Composite_gangliocytoma/neuroma_and_neuroendocrine_tumour|Composite gangliocytoma/neuroma and neuroendocrine tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Lipoma|Lipoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Benign_vascular_tumours|Benign vascular tumours]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:PEComa|PEComa]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Glomangioma_and_glomus_tumour|Glomangioma and glomus tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Angiosarcoma|Angiosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Leiomyoma|Leiomyoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Rhabdomyosarcomas|Rhabdomyosarcomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Schwannoma|Schwannoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Neurofibroma|Neurofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:IgG4-related_disease|IgG4-related disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Extranodal_marginal_zone_lymphoma|Extranodal marginal zone lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Germ_cell_tumours_in_endocrine_organs|Germ cell tumours in endocrine organs]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Teratomas_with_endocrine_differentiation|Teratomas with endocrine differentiation]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Metastasis_to_the_pituitary_gland|Metastasis to the pituitary gland]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Metastasis_to_the_thyroid_gland|Metastasis to the thyroid gland]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Metastasis_to_the_adrenal_gland|Metastasis to the adrenal gland]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Multiple_endocrine_neoplasia_type_4|Multiple endocrine neoplasia type 4]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Multiple_endocrine_neoplasia_type_5_(MAX-related_tumours)|Multiple endocrine neoplasia type 5 (MAX-related tumours)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Carney_complex|Carney complex]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:McCune-Albright_syndrome|McCune-Albright syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Glucagon_cell_hyperplasia_and_neoplasia|Glucagon cell hyperplasia and neoplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:MAFA-related_familial_insulinomatosis|MAFA-related familial insulinomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Syndromic_familial_follicular_cell-derived_thyroid_tumours|Syndromic familial follicular cell-derived thyroid tumours]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[ENDO5:Non-syndromic_familial_follicular_cell-derived_thyroid_tumours|Non-syndromic familial follicular cell-derived thyroid tumours]]
|Disease
|Disease
|
|
Retrieved from "https://test.ccga.io/index.php/ENDO5:Volunteer_Assignments_and_Opportunities"